Physician profile
Michael P Conley
NPI 1386632255
$2,064.47
in general payments reported to CMS, 2019-2025
28 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $65.24 · 2021: $348 · 2022: $509 · 2023: $320 · 2024: $216 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649 · Education: $94.00 · Entertainment: $13.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.57 |
| Education | $94.00 |
| Entertainment | $13.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $315.00 | 2019-2022 | |
| Astellas Pharma US INC | $214.55 | 2019-2025 | Veozah |
| Exeltis, USA INC. | $213.68 | 2019-2024 | Slynd |
| Abbvie INC. | $168.55 | 2019-2023 | Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $163.97 | 2019-2025 | |
| Millicent US INC | $105.60 | 2019-2025 | Intrarosa, Femlyv, Femring |
| Pfizer INC. | $102.38 | 2020-2023 | |
| Mayne Pharma Commercial LLC | $100.94 | 2022-2025 | |
| Coopersurgical, INC. | $79.28 | 2019-2024 | Paragard T 380a |
| Sage Therapeutics, LLC | $69.14 | 2024-2025 | Zurzuvae |
| Dysis Medical, INC. | $65.76 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $57.90 | 2019-2020 | |
| Agile Therapeutics, INC. | $52.09 | 2021-2022 | |
| Avion Pharmaceuticals | $41.99 | 2021-2023 | Balcoltra |
| Daiichi Sankyo INC. | $40.15 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $36.36 | 2023-2025 | Myfembree |
| Evofem Biosciences, INC. | $34.22 | 2021-2022 | |
| Organon LLC | $30.06 | 2022-2023 | Nexplanon |
| Therapeuticsmd, INC. | $29.48 | 2019-2021 | |
| Hologic Sales and Service, LLC | $25.29 | 2023 | Coolseal Generator, Acessa Provu System |
| Roche Diagnostics Corporation | $20.97 | 2021 | |
| Exact Sciences Corporation | $19.93 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $14.17 | 2019 | |
| Provepharm INC. | $13.15 | 2024 | Bludigo |
| Allergan, INC. | $13.13 | 2020 | |
| Merck Sharp & Dohme LLC | $12.84 | 2021 | |
| Medicem INC. | $12.05 | 2021 | |
| Lupin INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Conley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.